The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Open accessAbstract
Parkinson's disease (PD) is characterized by intracellular inclusions of aggregated and misfolded α-Synuclein (α-Syn), and the loss of dopaminergic (DA) neurons in the brain. The resulting motor abnormalities mark the progression of PD, while non-motor symptoms can already be identified during early, prodromal stages of disease. Recent studies provide evidence that during this early prodromal phase, synaptic and axonal abnormalities occur before the degenerative loss of neuronal cell bodies. These early phenotypes can be attributed to synaptic accumulation of toxic α-Syn. Under physiological conditions, α-Syn functions in its native conformation as a soluble monomer. However, PD patient brains are characterized by intracellular inclusions of insoluble fibrils. Yet, oligomers and protofibrils of α-Syn have been identified to be the most toxic species, with their accumulation at presynaptic terminals affecting several steps of neurotransmitter release. First, high levels of α-Syn alter the size of synaptic vesicle pools and impair their trafficking. Second, α-Syn overexpression can either misregulate or redistribute proteins of the presynaptic SNARE complex. This leads to deficient tethering, docking, priming and fusion of synaptic vesicles at the active zone (AZ). Third, α-Syn inclusions are found within the presynaptic AZ, accompanied by a decrease in AZ protein levels. Furthermore, α-Syn overexpression reduces the endocytic retrieval of synaptic vesicle membranes during vesicle recycling. These presynaptic alterations mediated by accumulation of α-Syn, together impair neurotransmitter exocytosis and neuronal communication. Although α-Syn is expressed throughout the brain and enriched at presynaptic terminals, DA neurons are the most vulnerable in PD, likely because α-Syn directly regulates dopamine levels. Indeed, evidence suggests that α-Syn is a negative modulator of dopamine by inhibiting enzymes responsible for its synthesis. In addition, α-Syn is able to interact with and reduce the activity of VMAT2 and DAT. The resulting dysregulation of dopamine levels directly contributes to the formation of toxic α-Syn oligomers. Together these data suggest a vicious cycle of accumulating α-Syn and deregulated dopamine that triggers synaptic dysfunction and impaired neuronal communication, ultimately causing synaptopathy and progressive neurodegeneration in Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“The accumulation of α-Syn in LB undergo an ascending pattern of distribution, from the lower brainstem and olfactory bulb into the limbic system and ultimately to the neocortex (Braak et al., 2003).”
BackgroundSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Several dominant-inherited single point mutations in SNCA gene have been identified in families that develop early onset PD (Polymeropoulos, 1997; Krüger et al., 1998; Zarranz et al., 2004; Appel-Cresswell et al., 2013; Lesage et al., 2013; Pasanen et al., 2014).”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“This hypothesis predicts that any disturbance inducing a negative energy balance would be especially dangerous to DA neurons, placing them at high risk in case of energy failure, such as mitochondrial dysfunction, which has been shown to play an important role in PD (Lin and Beal, 2006).”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547 · cited 1×
“The SV are locally loaded with neurotransmitter, hence being recycled to allow another round of exo-endocytotic membrane cycling (Südhof, 2004; Gross and von Gersdorff, 2016).”
BackgroundMolecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“The increased stability and longer half-life of mutant forms of α-Syn, such as A30P and A53T, increase their potential of aggregation (Bennett et al., 1999; Cuervo et al., 2004).”
BackgroundLang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,812
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · cited 1×
“…α-Syn has been shown to accumulate in axons (Braak et al., 1999) and in the presynaptic terminal (Kramer and SchulzSchaeffer, 2007), suggesting these pathogenic accumulations are a key trigger of onset and formation of PD-related synaptopathy (Stefanis, 2012; Schirinzi et al., 2016) (Box 1).”
BackgroundAlpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Cell diversity and network dynamics in photosensitive human brain organoids
Quadrato, G., Nguyen, T., Macosko, E. Z., Sherwood, J. L., Min Yang, S., Berger, D. R., Maria, N., Scholvin, J., Goldman, M., Kinney, J. P., et al. (2017) · Nature · doi:10.1038/nature22047 · Cited by 1,321 · cited 1×
“Moreover, organoids develop neuronal networks that can be modulated by sensory stimulation (Quadrato et al., 2017).”
BackgroundPathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Südhof, T. C. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.012 · Cited by 1,251 · cited 7×
“Synapses are composed of a presynaptic terminal, synaptic cleft and postsynaptic terminal which require a complex and tight regulation for proper neurotransmission to occur (Figure 4; Südhof and Rizo, 2011; Südhof, 2012).”
BackgroundInfluentialLang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Neurotransmitter Release: The Last Millisecond in the Life of a Synaptic Vesicle
Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.022 · Cited by 1,197
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 1×
“Loss of DA neurons in the SN leads to marked decrease of dopamine levels in synaptic terminals of the dorsal striatum (Figures 1A,B), ultimately leading to a loss of the nigrostriatal pathway (Cheng et al., 2010).”
BackgroundGoedert, M. (2015) · Science · doi:10.1126/science.1255555 · Cited by 976
Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.
Stenmark, H., Parton, R. G., Steele‐Mortimer, O., Lütcke, A., Gruenberg, J., & Zerial, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06381.x · Cited by 968
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 966
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Disease modeling in stem cell-derived 3D organoid systems
Dutta, D., Heo, I., & Clevers, H. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.007 · Cited by 838
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
The release of neural transmitter substances
Hubbard, J. I. (1970) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(70)90283-x · Cited by 715
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 711
Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation
Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion
Wang, Y., Okamoto, M., Schmitz, F., Hofmann, K., & Südhof, T. C. (1997) · Nature · doi:10.1038/41580 · Cited by 684
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Appel‐Cresswell, S., Vilarino‐Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 667
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 641
Schulz-Schaeffer, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0711-0 · Cited by 627
Structure of the toxic core of α-synuclein from invisible crystals
Rodriguez, J. A., Ivanova, M. I., Sawaya, M. R., Cascio, D., Reyes, F. E., Shi, D., Sangwan, S., Guenther, E. L., Johnson, L. M., Zhang, M., et al. (2015) · Nature · doi:10.1038/nature15368 · Cited by 619
(2004) · doi:10.1002/ana.10846 · Cited by 614
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 5×
“Mechanistically, α-Syn decreases TH activity by reducing its phosphorylation in vitro (Perez et al., 2002; Peng et al., 2005) as TH is activated by phosphorylation of seryl residues in the TH regulatory domain (Alerte et al., 2008).”
BackgroundInfluentialA timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150642 · Cited by 573
Kramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571
The Synucleinopathies: Twenty Years On
Goedert, M., Jakes, R., & Spillantini, M. G. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179005 · Cited by 569
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 536
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., Caldwell, K. A., Caldwell, G. A., Rochet, J.-C., McCaffery, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710685105 · Cited by 523
Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513
Sudhof, T. C., & Rizo, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005637 · Cited by 510
Axon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
Gilley, J., & Coleman, M. P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000300 · Cited by 472 · cited 1×
“The neuroprotective effects of mammalian NMNAT2 has been explored in more detail in axonal degeneration, where loss of NMNAT2 is considered to be a physiological stimulus in severed axons and their subsequent Wallerian degeneration (Gilley and Coleman, 2010).”
BackgroundDefects in trafficking bridge Parkinson’s disease pathology and genetics
Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462
Saheki, Y., & De Camilli, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005645 · Cited by 457
LEE, F. J. S., LIU, F., PRISTUPA, Z. B., & NIZNIK, H. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0334com · Cited by 455
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 422
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Mechanisms of dopamine transporter regulation in normal and disease states
Vaughan, R. A., & Foster, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.005 · Cited by 419
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V., Chaudhry, F. A., Edwards, R. H., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 415
Shirataki, H., Kaibuchi, K., Sakoda, T., Kishida, S., Yamaguchi, T., Wada, K., Miyazaki, M., & Takai, Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2061 · Cited by 398
Chung, C. Y., Koprich, J. B., Siddiqi, H., & Isacson, O. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5427-08.2009 · Cited by 391
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Di Monte, D. A., Emson, P. C., & Miller, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 388
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386
Effects of Curvature and Composition on α-Synuclein Binding to Lipid Vesicles
Middleton, E. R., & Rhoades, E. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.07.056 · Cited by 376
A Pathologic Cascade Leading to Synaptic Dysfunction in -Synuclein-Induced Neurodegeneration
Scott, D. A., Tabarean, I., Tang, Y., Cartier, A., Masliah, E., & Roy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1091-10.2010 · Cited by 353
Diao, J., Burré, J., Vivona, S., Cipriano, D. J., Sharma, M., Kyoung, M., Südhof, T. C., & Brunger, A. T. (2013) · eLife · doi:10.7554/elife.00592 · Cited by 350
Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 348
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
Janezic, S., Threlfell, S., Dodson, P. D., Dowie, M. J., Taylor, T. N., Potgieter, D., Parkkinen, L., Senior, S. L., Anwar, S., Ryan, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309143110 · Cited by 344 · cited 3×
“…of AZ proteins to overcome the upstream deleterious effects caused by toxic α-Syn, such as alterations of SV pools, SNAREs, and intracellular trafficking that together lead to impaired neurotransmitter exocytosis (Larsen et al., 2006; Nemani et al., 2010; Scott et al., 2010; Janezic et al., 2013).”
BackgroundThe role of α-synuclein in Parkinson's disease: insights from animal models
Maries, E., Dass, B., Collier, T. J., Kordower, J. H., & Steece-Collier, K. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1199 · Cited by 344
Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
Ingelsson, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00408 · Cited by 344
Molecular organization of the presynaptic active zone
Schoch, S., & Gundelfinger, E. D. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0244-y · Cited by 333
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Duda, J. E., Giasson, B. I., Mabon, M. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Annals of Neurology · doi:10.1002/ana.10279 · Cited by 329
Games, D., Valera, E., Spencer, B., Rockenstein, E., Mante, M., Adame, A., Patrick, C., Ubhi, K., Nuber, S., Sacayon, P., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5314-13.2014 · Cited by 322
Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
Vargas, K. J., Makani, S., Davis, T., Westphal, C. H., Castillo, P. E., & Chandra, S. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4787-13.2014 · Cited by 320
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease
Milnerwood, A. J., & Raymond, L. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.08.002 · Cited by 312
Dopamine receptors and transporters in Parkinson's disease and schizophrenia
Seeman, P., & Niznik, H. B. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2197154 · Cited by 300
Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking
Choi, B.-K., Choi, M.-G., Kim, J.-Y., Yang, Y., Lai, Y., Kweon, D.-H., Lee, N. K., & Shin, Y.-K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218424110 · Cited by 300
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Lundblad, M., Decressac, M., Mattsson, B., & Björklund, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200575109 · Cited by 292
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease
Garcia-Reitböck, P., Anichtchik, O., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B., Della Corte, L., Spano, P., Tofaris, G. K., et al. (2010) · Brain · doi:10.1093/brain/awq132 · Cited by 292
Synaptic Dysfunction in Parkinson’s Disease
Picconi, B., Piccoli, G., & Calabresi, P. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_24 · Cited by 290
A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity?
Dulubova, I., Lou, X., Lu, J., Huryeva, I., Alam, A., Schneggenburger, R., Südhof, T. C., & Rizo, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600753 · Cited by 289 · cited 1×
“…Munc13 and RIM, designed to capture SVs for final membrane attachment called tethering and to prepare them for synaptic release (Wang et al., 1997; Dulubova et al., 2005). α-Syn was shown to interact and cause defects in vesicular trafficking pathways including those taking place at the…”
BackgroundThe Concept of Prodromal Parkinson’s Disease
Mahlknecht, P., Seppi, K., & Poewe, W. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150685 · Cited by 288
Alpha-synuclein: from secretion to dysfunction and death
Marques, O., & Outeiro, T. F. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.94 · Cited by 286
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Venda, L. L., Cragg, S. J., Buchman, V. L., & Wade-Martins, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.09.004 · Cited by 285
Synaptic Vesicle Pools and Dynamics
Alabi, A. A., & Tsien, R. W. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a013680 · Cited by 284 · cited 7×
“α-Syn Affects Synaptic Vesicle Pools and Their Trafficking in the Presynaptic Terminal The SV pools can be divided accordingly to the number of SVs and distance from the AZ (Südhof, 2000; Alabi and Tsien, 2012).”
BackgroundInfluentialThe Synaptic VesicleCycle Revisited
Südhof, T. C. (2000) · Neuron · doi:10.1016/s0896-6273(00)00109-4 · Cited by 276
Genetic Analysis of Pathways to Parkinson Disease
Hardy, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.014 · Cited by 274
Retrograde Axonal Degeneration in Parkinson Disease
Tagliaferro, P., & Burke, R. E. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150769 · Cited by 272 · cited 2×
“Thus, synaptic dysfunction is considered to be the first step followed by active deconstruction of axons and loss of neuronal connectivity, eventually leading to the death of neuronal perikarya (Figure 3; Scott et al., 2010; Lu et al., 2014; Morales et al., 2015; Schulz-Schaeffer, 2015; Calo et al., 2016; Grosch et al…”
BackgroundLotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02481 · Cited by 249 · cited 2×
“Mechanistically, α-Syn decreases TH activity by reducing its phosphorylation in vitro (Perez et al., 2002; Peng et al., 2005) as TH is activated by phosphorylation of seryl residues in the TH regulatory domain (Alerte et al.”
Backgroundα-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis
Scott, D., & Roy, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0535-12.2012 · Cited by 243
Braak, H., Sandmann-Keil, D., Gai, W., & Braak, E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00208-6 · Cited by 242
CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity
Sharma, M., Burré, J., & Südhof, T. C. (2011) · Nature Cell Biology · doi:10.1038/ncb2131 · Cited by 226
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
Bereczki, E., Branca, R. M., Francis, P. T., Pereira, J. B., Baek, J.-H., Hortobágyi, T., Winblad, B., Ballard, C., Lehtiö, J., & Aarsland, D. (2018) · Brain · doi:10.1093/brain/awx352 · Cited by 220 · cited 1×
“Studies investigating levels of synaptic proteins belonging to the SNARE complex in PD, PD with dementia (PDD) and DLB post-mortem samples also reported misregulation of proteins belonging to the SNARE complex (Kramer and Schulz-Schaeffer, 2007; Dijkstra et al., 2015; Bereczki et al., 2016, 2018).”
BackgroundDopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Mor, D. E., Tsika, E., Mazzulli, J. R., Gould, N. S., Kim, H., Daniels, M. J., Doshi, S., Gupta, P., Grossman, J. L., Tan, V. X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4641 · Cited by 217
Pranke, I. M., Morello, V., Bigay, J., Gibson, K., Verbavatz, J.-M., Antonny, B., & Jackson, C. L. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201011118 · Cited by 211
A molecular machine for neurotransmitter release: synaptotagmin and beyond
Südhof, T. C. (2013) · Nature Medicine · doi:10.1038/nm.3338 · Cited by 202
NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration
Zhai, R. G., Zhang, F., Hiesinger, P. R., Cao, Y., Haueter, C. M., & Bellen, H. J. (2008) · Nature · doi:10.1038/nature06721 · Cited by 201 · cited 1×
“However, this role does not require the enzymatic function of NMNAT, as the inactive form of dNMNAT was able to protect Drosophila photoreceptors against activity-induced degeneration (Zhai et al., 2006, 2008).”
BackgroundInduction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein
Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101318200 · Cited by 200
Attenuation of dopamine transporter activity by α-synuclein
Wersinger, C., & Sidhu, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00097-1 · Cited by 197
Mukherjee, K., Yang, X., Gerber, S. H., Kwon, H.-B., Ho, A., Castillo, P. E., Liu, X., & Südhof, T. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002307107 · Cited by 195
Synaptic failure and α‐synuclein
Calo, L., Wegrzynowicz, M., Santivañez‐Perez, J., & Grazia Spillantini, M. (2016) · Movement Disorders · doi:10.1002/mds.26479 · Cited by 170
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.005 · Cited by 167 · cited 2×
“Studies investigating levels of synaptic proteins belonging to the SNARE complex in PD, PD with dementia (PDD) and DLB post-mortem samples also reported misregulation of proteins belonging to the SNARE complex (Kramer and Schulz-Schaeffer, 2007; Dijkstra et al., 2015; Bereczki et al., 2016, 2018).”
BackgroundDijkstra, A. A., Ingrassia, A., de Menezes, R. X., van Kesteren, R. E., Rozemuller, A. J. M., Heutink, P., & van de Berg, W. D. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128651 · Cited by 167
An updated review of Parkinson's disease genetics and clinicopathological correlations
Ferreira, M., & Massano, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12616 · Cited by 167
Pifl, C., Rajput, A., Reither, H., Blesa, J., Cavada, C., Obeso, J. A., Rajput, A. H., & Hornykiewicz, O. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5456-13.2014 · Cited by 167
Drosophila NMNAT Maintains Neural Integrity Independent of Its NAD Synthesis Activity
Zhai, R. G., Cao, Y., Hiesinger, P. R., Zhou, Y., Mehta, S. Q., Schulze, K. L., Verstreken, P., & Bellen, H. J. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040416 · Cited by 166
Riemensperger, T., Issa, A.-R., Pech, U., Coulom, H., Nguyễn, M.-V., Cassar, M., Jacquet, M., Fiala, A., & Birman, S. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.032 · Cited by 166
Synaptic dysfunction in Parkinson's disease
Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 160
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies
Marui, W., Iseki, E., Nakai, T., Miura, S., Kato, M., Uéda, K., & Kosaka, K. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00006-0 · Cited by 160
Mitochondrial Dysfunction in Parkinson's Disease
Keane, P. C., Kurzawa, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson's Disease · doi:10.4061/2011/716871 · Cited by 160
Early synaptic dysfunction in Parkinson's disease: Insights from animal models
Schirinzi, T., Madeo, G., Martella, G., Maltese, M., Picconi, B., Calabresi, P., & Pisani, A. (2016) · Movement Disorders · doi:10.1002/mds.26620 · Cited by 160
Synucleins Have Multiple Effects on Presynaptic Architecture
Vargas, K. J., Schrod, N., Davis, T., Fernandez-Busnadiego, R., Taguchi, Y. V., Laugks, U., Lucic, V., & Chandra, S. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.023 · Cited by 160
Caminiti, S. P., Presotto, L., Baroncini, D., Garibotto, V., Moresco, R. M., Gianolli, L., Volonté, M. A., Antonini, A., & Perani, D. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.03.011 · Cited by 151
Grosch, J., Winkler, J., & Kohl, Z. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00293 · Cited by 150
Kouroupi, G., Taoufik, E., Vlachos, I. S., Tsioras, K., Antoniou, N., Papastefanaki, F., Chroni-Tzartou, D., Wrasidlo, W., Bohl, D., Stellas, D., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617259114 · Cited by 148
Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking
Wang, S. S. H., Held, R. G., Wong, M. Y., Liu, C., Karakhanyan, A., & Kaeser, P. S. (2016) · Neuron · doi:10.1016/j.neuron.2016.07.005 · Cited by 143
The NMN/NaMN adenylyltransferase (NMNAT) protein family
Lau, C., Niere, M., & Ziegler, M. (2009) · Frontiers in bioscience · doi:10.2741/3252 · Cited by 142
Transcellular spreading of huntingtin aggregates in the Drosophila brain
Babcock, D. T., & Ganetzky, B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516217112 · Cited by 142
Zhang, L., Zhang, C., Zhu, Y., Cai, Q., Chan, P., Uéda, K., Yu, S., & Yang, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.067 · Cited by 134
Synapses in neurodegenerative diseases
Bae, J. R., & Kim, S. H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.5.038 · Cited by 131
Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Tehranian, R., Montoya, S. E., Laar, A. D. V., Hastings, T. G., & Perez, R. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04146.x · Cited by 128
The dopamine transporter: Importance in Parkinson's disease
Nutt, J. G., Carter, J. H., & Sexton, G. J. (2004) · Annals of Neurology · doi:10.1002/ana.20089 · Cited by 122
Membrane Curvature Sensing by Amphipathic Helices
Jensen, M. B., Bhatia, V., Jao, C., Rasmussen, J. E., Pedersen, S. L., Jensen, K., Langen, R., & Stamou, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271130 · Cited by 120
Tosatto, L., Horrocks, M. H., Dear, A. J., Knowles, T. P. J., Serra, M. D., Cremades, N., Dobson, C. M., & Klenerman, D. (2015) · Scientific Reports · doi:10.1038/srep16696 · Cited by 119
Chen, R. H., Wislet‐Gendebien, S., Samuel, F., Visanji, N. P., Zhang, G., Marsilio, D., Langman, T., Fraser, P. E., & Tandon, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.439497 · Cited by 116
Ali, Y., Ruan, K., & Zhai, R. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr449 · Cited by 116
Kohl, Z., Abdallah, N. M. ‐. B., Vogelgsang, J. S., Tischer, L., Deusser, J., Amato, D., Anderson, S., Müller, C. P., Rieß, O., Masliah, E., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.021 · Cited by 112
Ljungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107 · cited 3×
“NMNAT2 alterations were also found in a mouse model of tauopathy expressing mis-sense mutation P301L, found in some frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) cases (Ljungberg et al., 2012).”
BackgroundAbnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease
Dalfó, E., Barrachina, M., Rosa, J. L., Ambrosio, S., & Ferrer, I. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.001 · Cited by 106
RIM proteins and their role in synapse function
Mittelstaedt, T., Álvarez‐Barón, E., & Schoch, S. (2010) · Biological Chemistry · doi:10.1515/bc.2010.064 · Cited by 103
Guo, J. T., Chen, A. Q., Kong, Q., Zhu, H., Ma, C. M., & Qin, C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9227-0 · Cited by 102
Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease
Fang, F., Yang, W., Florio, J. B., Rockenstein, E. M., Spencer, B. J., Orain, X., Dong, S. X., Li, H., Chen, X., Sung, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04232-4 · Cited by 102
Acute increase of α-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation
Busch, D. J., Oliphint, P., Walsh, R. B., Banks, S. M. L., Woods, W. S., George, J., & Morgan, J. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-02-0708 · Cited by 99
Alerte, T. N. M., Akinfolarin, A. A., Friedrich, E. E., Mader, S. A., Hong, C.-S., & Perez, R. G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.014 · Cited by 98 · cited 2×
“Mechanistically, α-Syn decreases TH activity by reducing its phosphorylation in vitro (Perez et al., 2002; Peng et al., 2005) as TH is activated by phosphorylation of seryl residues in the TH regulatory domain (Alerte et al., 2008).”
BackgroundRahmati, N., Veloz, M. F. V., Xu, J., Barone, S., Hamida, N. R. B., Schonewille, M., Hoebeek, F. E., Soleimani, M., & Zeeuw, C. I. D. (2016) · eNeuro · doi:10.1523/eneuro.0028-16.2016 · Cited by 96
The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
Longhena, F., Faustini, G., Missale, C., Pizzi, M., Spano, P., & Bellucci, A. (2017) · Neural Plasticity · doi:10.1155/2017/5012129 · Cited by 93
NMNATs, evolutionarily conserved neuronal maintenance factors
Ali, Y. O., Li-Kroeger, D., Bellen, H. J., Zhai, R. G., & Lu, H.-C. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.002 · Cited by 91 · cited 3×
“NMNAT1 is a nuclear protein, NMNAT2 is localized to the Golgi apparatus and NMNAT 3 is predominantly mitochondrial (Ali et al., 2013).”
BackgroundNonaggregated α-Synuclein Influences SNARE-Dependent Vesicle Docking via Membrane Binding
Lai, Y., Kim, S., Varkey, J., Lou, X., Song, J., Diao, J., Langen, R., & Shin, Y. (2014) · Biochemistry · doi:10.1021/bi5002536 · Cited by 89
Chutna, O., Gonçalves, S. A., Villar‐Piqué, A., Guerreiro, P. S., Marijanovic, Z., Mendes, T., Ramalho, J. S., Emmanouilidou, E., Ventura, S., Klucken, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu391 · Cited by 89
Molecular Machines Regulating the Release Probability of Synaptic Vesicles at the Active Zone
Körber, C., & Kuner, T. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00005 · Cited by 85
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
Lu, X., Kim‐Han, J. S., Harmon, S., Sakiyama‐Elbert, S. E., & O’Malley, K. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-17 · Cited by 84
Synaptopathy: dysfunction of synaptic function?
Brose, N., O'Connor, V. M., & Skehel, P. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380443 · Cited by 82
Gonçalves, S. A., Macedo, D., Raquel, H., Simões, P. D., Giorgini, F., Ramalho, J. S., Barral, D. C., Moita, L. F., & Outeiro, T. F. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005995 · Cited by 81
NMNAT: It’s an NAD+ synthase… It’s a chaperone… It’s a neuroprotector
Brazill, J. M., Li, C. V., Zhu, Y., & Zhai, R. G. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.014 · Cited by 74
The Rab family of proteins: 25 years on
Kelly, E. E., Horgan, C. P., Goud, B., & McCaffrey, M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120203 · Cited by 72
Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 72
Functions of Rab Proteins at Presynaptic Sites
Binotti, B., Jahn, R., & Chua, J. J. E. (2016) · Cells · doi:10.3390/cells5010007 · Cited by 72
α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals
Xu, J., Wu, X.-S., Sheng, J., Zhang, Z., Yue, H., Sun, L., Sgobio, C., Lin, X. Z., Peng, S., Jin, Y., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3627-15.2016 · Cited by 68
Silencing α-Synuclein Gene Expression Enhances Tyrosine Hydroxylase Activity in MN9D Cells
Liu, D., Jin, L., Wang, H., Zhao, H., Zhao, C., Duan, C., Lu, L., Wu, B., Yu, S., Chan, P., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9599-7 · Cited by 65
Alpha-Synuclein is localized in a subpopulation of rat brain synaptic vesicles
Lee, S., Jeon, H., & Kandror, K. V. (2008) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2008-1717 · Cited by 64
Wersinger, C., Prou, D., Vernier, P., Niznik, H. B., & Sidhu, A. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00124-6 · Cited by 63
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson’s Disease?
Schulz‐Schaeffer, W. (2015) · Biomolecules · doi:10.3390/biom5031467 · Cited by 62
Presynaptic protein homeostasis and neuronal function
Wang, Y., Lauwers, E., & Verstreken, P. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.015 · Cited by 61
Feng, Y., Yan, T., Zheng, J. H., Ge, X., Mu, Y., Zhang, Y., Wu, D., Du, J., & Zhai, Q. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22498 · Cited by 52
Ocampo, A., Liu, J., & Barrientos, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt016 · Cited by 48
The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model
Moráles, I., Sánchez, A., Rodriguez‐Sabate, C., & Rodríguez, M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.019 · Cited by 35
Yamamoto, S., Fukae, J., Mori, H., Mizuno, Y., & Hattori, N. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.068 · Cited by 26
Zang, S., Ali, Y., Ruan, K., & Zhai, R. G. (2012) · EMBO Reports · doi:10.1038/embor.2012.181 · Cited by 25
Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila
Rallis, A., Lu, B., & Ng, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.117259 · Cited by 25
Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease
Roy, S. (2017) · Nature Neuroscience · doi:10.1038/nn.4660 · Cited by 22
Rab3-GEF Controls Active Zone Development at the Drosophila Neuromuscular Junction
Bae, H., Chen, S., Roche, J. P., Ai, M., Wu, C., DiAntonio, A., & Graf, E. R. (2016) · eNeuro · doi:10.1523/eneuro.0031-16.2016 · Cited by 18
Gross, O. P., & von Gersdorff, H. (2016) · eLife · doi:10.7554/elife.17692 · Cited by 18
Chen, S., Gendelman, H. K., Roche, J. P., Alsharif, P., & Graf, E. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136938 · Cited by 15
Cited by
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05672-9 · Cited by 817
Mahul-Mellier, A.-L., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F., Leleu, M., Knott, G. W., & Lashuel, H. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913904117 · Cited by 710
Trial of Cinpanemab in Early Parkinson’s Disease
Lang, A. E., Siderowf, A. D., Macklin, E. A., Poewe, W., Brooks, D. J., Fernandez, H. H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C. M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203395 · Cited by 351
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 307
Metadata
- Authors
- Bridi, J. C., & Hirth, F.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-02-19
- Volume
- 12
- Pages
- 80-80
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2790799100
- Cited by
- 378
- References
- 185
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.